Opening statements got underway on Wednesday in a lawsuit challenging the legality of California's law requiring publicly held companies to include women on their boards, a case that will test the state's authority to address disparities in corporate power.
SAN JOSE, Calif. Theranos founder Elizabeth Holmes on Tuesday faced prosecutors' questions about her relationship with former romantic and business partner Ramesh "Sunny" Balwani, a day after Holmes said that he had been abusive and controlling.
SAN JOSE, Calif., Nov 30 Theranos founder
Elizabeth Holmes is expected to face cross-examination by a
prosecutor on Tuesday, in what could be a pivotal moment in the
fraud trial of the blood-testing startup founder.
SAN JOSE, Calif. Theranos founder Elizabeth Holmes testified on Monday she was abused by her former romantic partner and Theranos executive Ramesh "Sunny" Balwani and that the relationship had a pervasive impact on her life during the time when she is accused of committing fraud.
SAN JOSE, Calif., Nov 29 Theranos founder
Elizabeth Holmes is due to testify for a fourth day at her fraud
trial in California on Monday and is expected to continue
portraying herself as an entrepreneur who faced challenges in
her attempt to reshape the blood-testing industry.
SAN JOSE, Calif. Theranos founder Elizabeth Holmes denied lying to Walgreens about her company's technology during her fraud trial on Tuesday, offering rationales for withholding key details about operations and internal reports.
SAN JOSE, Calif., Nov 23 Theranos founder
Elizabeth Holmes is expected to take the stand for a third day
on Tuesday in her trial on fraud charges tied to her startup
that once promised to revolutionize blood testing.
SAN JOSE, Calif. (Reuters) -Theranos founder Elizabeth Holmes defended her leadership at the now-defunct blood-testing startup on Monday, telling jurors at her fraud trial she had confidence in the company's technology and had seen positive results from early studies.
SAN JOSE, Calif., Nov 22 Theranos founder
Elizabeth Holmes is expected to retake the stand on Monday to
defend against charges of defrauding investors and patients
about the now-defunct blood-testing startup once valued at $9